Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Warren Buffett’s Long-Term Dividend Holds: Sanofi SA (ADR) (SNY) and More

International media and marketing company Gannett Co., Inc. (NYSE:GCI) gave impressive performance stretching back a year, netting a double-digit rise in share price spurred along by consistent earnings beats every single quarter. While overall sentiment is still positive for the stock, some analysts are becoming tepid as Gannett’s core business (newspaper sales) has seen more competition from the likes of News Corp (NASDAQ:NWSA) and falling circulation numbers from consumers. However, the stock continues to earn investors like Buffett a yield of 4.1%, which, when matched with the startling performance of the stock last year, means a respectable growth and income investment for those who have been in on a longer-term scale. Billionaire David Harding upped his position by 30% according to his last 13F filings.

Sanofi SA (ADR) (NYSE:SNY) is another high-dividend healthcare play on our list, earning a still-respectable yield of 3.6%. Once again, the stock provided significant gains on both the income and growth fronts for Buffett, despite their last quarterly earnings report showing negative growth in revenue versus the same quarter a year prior. Forward price-to-earnings ratios show a decline versus the same ratio calculated with the last twelve months earnings. We expect the stock price to come down to meet the reduced P/E numbers, as SNY will have to battle government regulations and increased distribution of generics in 2013. Abrams Capital Management maintains a $50 million position in the stock.

Last on our list of Buffett’s long-term dividend plays is General Electric Company (NYSE:GE) . GE barely made our list, as Berkshire Hathaway cut their position by almost 90% going into their Q3 13F filing last year. The fund started with roughly $140 million invested in the stock, yet only $13 million is left after they unwound that trade. Buffett is most likely taking profits here, as the stock has given a 25% return since the start of 2011. Additional income was given in GE’s 3.4% dividend yield. Steve Cohen of SAC Capital Advisors mirrored Buffett’s approach and reduced his bullish call position by over 60%.

The article Warren Buffett’s Long-Term Dividend Holds originally appeared on Fool.com and is written by Jake Mann.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!